Q2 2025 Earnings Call Transcript February 6, 2025 Operator: Hello, and thank you for standing by. My name is Regina, and I ...

Piper Sandler lowered the firm’s price target on Zoetis (ZTS) to $200 from $210 and keeps an Overweight rating on the shares. The firm cites ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Zoetis (ZTS – Research Report), with a price target ...

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the second quarter of 2025. The dividend will be paid on Tuesday, June 3, 2025, to all holders of ...

Let's examine three of my favorite dividend growth stocks -- ASML (NASDAQ: ASML), Wingstop (NASDAQ: WING), and Zoetis (NYSE: ZTS) -- and discuss what sets them apart from the crowd.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

After hours: February 7 at 7:57:12 PM EST Loading Chart for ZTS ...

University researchers have used that money to invent new products, including a widely used vaccine called Zoetis, used to prevent Lyme disease in dogs. Dr. Jonathan Isaacs created a device called ...